Oncologists urge frank evaluation of cancer drugs’ costs and value

Experts at the nation’s largest gathering of oncologists this week urged tough new approaches for reining in the skyrocketing cost of cancer drugs.

Pharmaceutical companies at the American Society of Clinical Oncology’s annual conference in Chicago touted new cancer therapies and potential breakthroughs. But some speakers argued that the U.S. healthcare system should explicitly consider cost-effectiveness in the drug approval and insurance coverage processes.

Read More

No Comments

Leave a Comment